Zimmer Biomet Holdings, Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 6.5B 7.4B 6.9B 6.8B
Cost of revenue 1.9B 2.1B 2.0B 2.0B
Gross profit 4.7B 5.3B 4.9B 4.9B
Operating expense
Research & development 372.6M 458.7M 406M 435.8M
Selling general and admin 2.5B 2.8B 2.8B 2.8B
Other operating expenses 33.8M 52.8M
Operating income 1.3B 1.5B 1.2B 1.0B
Non operating interest income
Income
Expense 185.7M 201.2M 164.8M 208.4M
Other income expense -233.1M -182.9M -623.8M -298M
Pretax income 882.9M 1.1B 403.5M 499M
Tax provision 111.9M 42.2M 112.3M 53.5M
Net income 771.0M 1.0B 232.4M 402.1M
Basic EPS 4.5 4.9 1.1 1.9
Diluted EPS 4.4 4.9 1.1 1.9
Basic average shares 173.0M 218.5M 218.1M 217.1M
Diluted average shares 173.0M 218.5M 218.1M 217.1M
EBITDA 2.1B 2.4B 2.0B 2.0B
Net income from continuing op. 771.0M 1.0B 291.2M 445.5M
Minority interests -1.5M -1.1M -1M -500K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 46 minutes

05:13
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).